Ecophysiology and dynamics of nitrogen removal bacteria in a sequencing batch reactor during wastewater treatment start‑up

Nitrogen removal communities performing wastewater treatment consist of ammonia oxidisers, nitrite oxidisers, denitrifiers, and anammox bacteria, and the proportion and activity of particular microbial groups depend not only on the physiochemical parameters of the bioreactor, but also on the composition of the inoculum. Nitrifiers and denitrifiers usually dominate in conventional wastewater treatment systems due to the fact that nitrification and denitrification are the most commonly used nitrogen removal processes. However, from the economical point of view in case of wastewater with high ammonia concentrations, anammox-based technologies are desirable for their treatment. The disadvantage of such systems is slow anammox bacteria growth, which extends an effective technological start-up. Thus, in this study, a fast start-up of the anammox process supported with an anammox-rich inoculum was performed in a sequencing batch reactor (SBR). Using anammox inoculation of SBR laboratory system, the start-up can be fastened to 85 days with 84.5% of nitrogen removal efficacy. The spatial distribution of nitrogen removal bacteria analysed with fluorescent in situ hybridisation revealed that anammox and nitrifiers are located side by side in the flocs and the relative number of ammonia and nitrite oxidisers decreased after 85 days of the experiment

Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 cohort studies

Aims We aimed to evaluate the association between metabolic syndrome (MetS) and long-term all-cause mortality. Methods The LIPIDOGRAM studies were carried out in the primary care in Poland in 2004, 2006 and 2015. MetS was diagnosed based on the National Cholesterol Education Program, Adult Treatment Panel III (NCEP/ATP III) and Joint Interim Statement (JIS) criteria. The cohort was divided into four groups: non-obese patients without MetS, obese patients without MetS, non-obese patients with MetS and obese patients with MetS. Differences in all-cause mortality was analyzed using Kaplan-Meier and Cox regression analyses. Results 45,615 participants were enrolled (mean age 56.3, standard deviation: 11.8 years; 61.7% female). MetS was diagnosed in 14,202 (31%) by NCEP/ATP III criteria, and 17,216 (37.7%) by JIS criteria. Follow-up was available for 44,620 (97.8%, median duration 15.3 years) patients. MetS was associated with increased mortality risk among the obese (hazard ratio, HR: 1.88 [95% CI, 1.79-1.99] and HR: 1.93 [95% CI 1.82-2.04], according to NCEP/ATP III and JIS criteria, respectively) and non-obese individuals (HR: 2.11 [95% CI 1.85-2.40] and 1.7 [95% CI, 1.56-1.85] according to NCEP/ATP III and JIS criteria respectively). Obese patients without MetS had a higher mortality risk than non-obese patients without MetS (HR: 1.16 [95% CI 1.10-1.23] and HR: 1.22 [95%CI 1.15-1.30], respectively in subgroups with NCEP/ATP III and JIS criteria applied). Conclusions MetS is associated with increased all-cause mortality risk in non-obese and obese patients. In patients without MetS obesity remains significantly associated with mortality. The concept of metabolically healthy obesity should be revised